1. Home
  2. UBS vs MRK Comparison

UBS vs MRK Comparison

Compare UBS & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UBS Group AG Registered

UBS

UBS Group AG Registered

HOLD

Current Price

$49.77

Market Cap

154.1B

Sector

Finance

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$115.76

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBS
MRK
Founded
1862
2000
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.1B
268.7B
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
UBS
MRK
Price
$49.77
$115.76
Analyst Decision
Buy
Buy
Analyst Count
2
17
Target Price
$60.30
$125.59
AVG Volume (30 Days)
2.3M
8.2M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
1.29%
3.06%
EPS Growth
N/A
8.01
EPS
N/A
N/A
Revenue
N/A
$65,011,000,000.00
Revenue This Year
$7.40
$3.61
Revenue Next Year
$2.83
$5.41
P/E Ratio
$17.22
N/A
Revenue Growth
N/A
1.31
52 Week Low
$30.39
$76.66
52 Week High
$49.36
$125.14

Technical Indicators

Market Signals
Indicator
UBS
MRK
Relative Strength Index (RSI) 66.50 46.67
Support Level $46.47 $112.96
Resistance Level N/A $123.93
Average True Range (ATR) 0.81 2.95
MACD 0.02 -0.11
Stochastic Oscillator 92.15 15.38

Price Performance

Historical Comparison
UBS
MRK

About UBS UBS Group AG Registered

UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: